Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests
Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech
Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen
Vericel Corporation 2026 Q1 - Results - Earnings Call Presentation
Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth
Vericel Q1 Earnings Call Highlights
Vericel (VCEL) Q1 2026 Earnings Transcript
HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $70
Vericel Corporation (VCEL) Q1 2026 Earnings Call Transcript
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
Vericel Raises FY2026 Sales Guidance from $316.000M-$326.000M to $326.000M-$336.000M vs $323.377M Est
Vericel Q1 EPS $(0.12) Beats $(0.15) Estimate, Sales $68.425M Beat $63.638M Estimate
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.